Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -39.89M | -447.44% | $ 8.92M |
3/31/2025 | $ -37.57M | -173.41% | $ 21.66M |
12/31/2024 | $ -34.09M | -96.19% | $ 35.44M |
9/30/2024 | $ -30.11M | -64.7% | $ 46.54M |
6/30/2024 | $ -26.75M | -104.84% | $ 25.52M |
3/31/2024 | $ -27.84M | -72.32% | $ 38.5M |
12/31/2023 | $ -25.34M | -80.96% | $ 31.3M |
9/30/2023 | $ -24.08M | -49.57% | $ 48.57M |
6/30/2023 | $ -26.05M | -132.16% | $ 19.71M |
3/31/2023 | $ -24.7M | -123.79% | $ 19.95M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for VYNE THERAPEUTICS INC is calculated as follows: FCF [ $ -128.23M ] / Market Cap [ $ 297.15M ]
(=) FCF Yield [ -43.16% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.36% |